{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:11:41Z","timestamp":1760055101582,"version":"build-2065373602"},"reference-count":73,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.medmal.2006.01.030","type":"journal-article","created":{"date-parts":[[2007,8,18]],"date-time":"2007-08-18T07:16:50Z","timestamp":1187421410000},"page":"368-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Traitement et\u00a0suivi des\u00a0phases secondaire et\u00a0tertiaire de\u00a0la\u00a0borr\u00e9liose de\u00a0Lyme"],"prefix":"10.1016","volume":"37","author":[{"given":"M.","family":"Mohseni Zadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.medmal.2006.01.030_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM200107123450207","article-title":"Lyme disease","volume":"345","author":"Steere","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"RR\u201313","key":"10.1016\/j.medmal.2006.01.030_bib2","first-page":"1","article-title":"Case definitions for public health surveillance","volume":"39","year":"1990","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"31","key":"10.1016\/j.medmal.2006.01.030_bib3","first-page":"590","article-title":"Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease","volume":"44","year":"1995","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"23","key":"10.1016\/j.medmal.2006.01.030_bib4","first-page":"741","article-title":"European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis","volume":"108","author":"Stanek","year":"1996","journal-title":"Wien. Klin. Wochenschr."},{"issue":"14","key":"10.1016\/j.medmal.2006.01.030_bib5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198504043121401","article-title":"Successful parenteral penicillin therapy of established Lyme arthritis","volume":"312","author":"Steere","year":"1985","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.medmal.2006.01.030_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1128\/AAC.31.2.164","article-title":"In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia\u00a0burgdorferi, to four antimicrobial agents","volume":"31","author":"Johnson","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.01.030_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1749-6632.1988.tb31869.x","article-title":"New chemotherapeutic approaches in the treatment of Lyme borreliosis","volume":"539","author":"Luft","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.medmal.2006.01.030_bib8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02013102","article-title":"In vitro and in vivo susceptibility of Borrelia\u00a0burgdorferi","volume":"6","author":"Mursic","year":"1987","journal-title":"Eur. J. Clin. Microbiol."},{"issue":"8596","key":"10.1016\/j.medmal.2006.01.030_bib9","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(88)92011-9","article-title":"Treatment of late Lyme borreliosis-randomised comparison of ceftriaxone and penicillin","volume":"1","author":"Dattwyler","year":"1988","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.medmal.2006.01.030_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF01644175","article-title":"Cefotaxime versus penicillin in the late stage of Lyme disease-prospective, randomized therapeutic study","volume":"18","author":"Hassler","year":"1990","journal-title":"Infection"},{"issue":"6","key":"10.1016\/j.medmal.2006.01.030_bib11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.1780370616","article-title":"Treatment of Lyme arthritis","volume":"37","author":"Steere","year":"1994","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.medmal.2006.01.030_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s100960050166","article-title":"Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis","volume":"17","author":"Oksi","year":"1998","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"5","key":"10.1016\/j.medmal.2006.01.030_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3476(86)80688-6","article-title":"Childhood Lyme arthritis: experience in an endemic area","volume":"109","author":"Eichenfield","year":"1986","journal-title":"J. Pediatr."},{"issue":"Suppl 1","key":"10.1016\/j.medmal.2006.01.030_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/314053","article-title":"Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America","volume":"31","author":"Wormser","year":"2000","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.medmal.2006.01.030_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0934-8840(98)80128-X","article-title":"The European Union Concerted Action World Wide Web site for Lyme borreliosis","volume":"287","author":"Smith","year":"1998","journal-title":"Zentralbl. Bakteriol."},{"issue":"6","key":"10.1016\/j.medmal.2006.01.030_bib16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.7326\/0003-4819-99-6-767","article-title":"Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin","volume":"99","author":"Steere","year":"1983","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.medmal.2006.01.030_bib17","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/infdis\/155.6.1322","article-title":"Ceftriaxone as effective therapy in refractory Lyme disease","volume":"155","author":"Dattwyler","year":"1987","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.medmal.2006.01.030_bib18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archneur.1989.00520470044025","article-title":"Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study","volume":"46","author":"Pfister","year":"1989","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.medmal.2006.01.030_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01644967","article-title":"Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children-a prospective study","volume":"19","author":"M\u00fcllegger","year":"1991","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.medmal.2006.01.030_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/infdis\/163.2.311","article-title":"Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis","volume":"163","author":"Pfister","year":"1991","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.medmal.2006.01.030_bib21","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1128\/AAC.33.7.1078","article-title":"Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis","volume":"33","author":"Dotevall","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.medmal.2006.01.030_bib22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1086\/515145","article-title":"Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis","volume":"28","author":"Dotevall","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.01.030_bib23","first-page":"74","article-title":"The use of doxycycline in nervous system Borrelia\u00a0burgdorferi infection","volume":"53","author":"Dotevall","year":"1988","journal-title":"Scand. J. Infect. Dis. Suppl."},{"issue":"8","key":"10.1016\/j.medmal.2006.01.030_bib24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/BF00328508","article-title":"Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin G","volume":"236","author":"Kohlhepp","year":"1989","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.medmal.2006.01.030_bib25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.44.7.1203","article-title":"Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis","volume":"44","author":"Karlsson","year":"1994","journal-title":"Neurology"},{"issue":"6\u20137","key":"10.1016\/j.medmal.2006.01.030_bib26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00365540510027228","article-title":"Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis","volume":"37","author":"Borg","year":"2005","journal-title":"Scand. J. Infect. Dis."},{"issue":"11\u201312","key":"10.1016\/j.medmal.2006.01.030_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00508-005-0361-8","article-title":"A comparison of two treatment regimens of ceftriaxone in late Lyme disease","volume":"117","author":"Dattwyler","year":"2005","journal-title":"Wien. Klin. Wochenschr."},{"issue":"2","key":"10.1016\/j.medmal.2006.01.030_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/00365549709035876","article-title":"Lyme carditis: a clinical presentation and long time follow-up","volume":"29","author":"Midttun","year":"1997","journal-title":"Scand. J. Infect. Dis."},{"issue":"1\u20132","key":"10.1016\/j.medmal.2006.01.030_bib29","first-page":"38","article-title":"Borrelia infection as a cause of carditis (a long-term study)","volume":"113","author":"Bartunek","year":"2001","journal-title":"Wien. Klin. Wochenschr."},{"issue":"13\u201314","key":"10.1016\/j.medmal.2006.01.030_bib30","first-page":"515","article-title":"Solitary borrelial lymphocytoma in adult patients","volume":"114","author":"Maraspin","year":"2002","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"10.1016\/j.medmal.2006.01.030_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF01780665","article-title":"Treatment of borrelial lymphocytoma","volume":"24","author":"Strle","year":"1996","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.medmal.2006.01.030_bib32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/00365549409011804","article-title":"Serological follow-up after treatment of Borrelia arthritis and acrodermatitis chronica atrophicans","volume":"26","author":"Hammers-Berggren","year":"1994","journal-title":"Scand. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.medmal.2006.01.030_bib33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2340\/0001555574424428","article-title":"Changes in Borrelia\u00a0burgdorferi-specific serum IgG antibody levels in patients treated for acrodermatitis chronica atrophicans","volume":"74","author":"Olsson","year":"1994","journal-title":"Acta Derm. Venereol."},{"issue":"5","key":"10.1016\/j.medmal.2006.01.030_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1600-0404.2002.01336.x","article-title":"Peripheral neuropathy in acrodermatitis chronica atrophicans-effect of treatment","volume":"106","author":"Kindstrand","year":"2002","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.medmal.2006.01.030_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01780666","article-title":"Success and failure in the treatment of acrodermatitis chronica atrophicans","volume":"24","author":"Aberer","year":"1996","journal-title":"Infection"},{"issue":"22\u201323","key":"10.1016\/j.medmal.2006.01.030_bib36","first-page":"911","article-title":"Principles of the diagnosis and antibiotic treatment of Lyme borreliosis","volume":"111","author":"Strle","year":"1999","journal-title":"Wien Klin Wochenschr"},{"issue":"4","key":"10.1016\/j.medmal.2006.01.030_bib37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF01644968","article-title":"Cutaneous manifestations of Lyme borreliosis","volume":"19","author":"Aberer","year":"1991","journal-title":"Infection"},{"issue":"5","key":"10.1016\/j.medmal.2006.01.030_bib38","first-page":"296","article-title":"Dermatological manifestations of Lyme borreliosis","volume":"14","author":"M\u00fcllegger","year":"2004","journal-title":"Eur. J. Dermatol."},{"issue":"5","key":"10.1016\/j.medmal.2006.01.030_bib39","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9394(14)73198-8","article-title":"Long-term effects of ceftriaxone treatment on intraocular Lyme borreliosis","volume":"116","author":"Suttorp-Schulten","year":"1993","journal-title":"Am. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.medmal.2006.01.030_bib40","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1517\/13543784.12.6.1003","article-title":"Current and novel therapies for Lyme disease","volume":"12","author":"Pavia","year":"2003","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"10","key":"10.1016\/j.medmal.2006.01.030_bib41","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1517\/13543784.12.10.1615","article-title":"The Lyme disease controversies continue","volume":"12","author":"Pavia","year":"2003","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.medmal.2006.01.030_bib42","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1086\/516171","article-title":"Tetracycline therapy for chronic Lyme disease","volume":"25","author":"Donta","year":"1997","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.medmal.2006.01.030_bib43","first-page":"PI136","article-title":"Macrolide therapy of chronic Lyme Disease","volume":"9","author":"Donta","year":"2003","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"10.1016\/j.medmal.2006.01.030_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.medmal.2006.01.030_bib45","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.medmal.2006.01.030_bib46","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.WNL.0000068030.26992.25","article-title":"Cognitive function in post-treatment Lyme disease: do additional antibiotics help?","volume":"60","author":"Kaplan","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.medmal.2006.01.030_bib47","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/infdis\/171.2.356","article-title":"Biliary complications in the treatment of unsubstantiated Lyme disease","volume":"171","author":"Ettestad","year":"1995","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.medmal.2006.01.030_bib48","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1086\/318138","article-title":"Death from inappropriate therapy for Lyme disease","volume":"31","author":"Patel","year":"2000","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.medmal.2006.01.030_bib49","first-page":"2025","article-title":"Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy","volume":"27","author":"Bentas","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.medmal.2006.01.030_bib50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1749-6632.1988.tb31915.x","article-title":"Corticosteroids for radicular pain in Bannwarth's syndrome. A double-blind, randomized, placebo-controlled trial","volume":"539","author":"Pfister","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.medmal.2006.01.030_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-93-1-8","article-title":"Lyme carditis: cardiac abnormalities of Lyme disease","volume":"93","author":"Steere","year":"1980","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.medmal.2006.01.030_bib52","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0161-6420(90)32474-0","article-title":"Episcleritis, conjunctivitis, and keratitis as ocular manifestations of Lyme disease","volume":"97","author":"Flach","year":"1990","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.medmal.2006.01.030_bib53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0161-6420(01)00868-5","article-title":"Posterior scleritis associated with Borrelia\u00a0burgdorferi (Lyme disease) infection","volume":"109","author":"Krist","year":"2002","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.medmal.2006.01.030_bib54","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/art.1780340817","article-title":"Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy","volume":"34","author":"Schoen","year":"1991","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.medmal.2006.01.030_bib55","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2106\/00004623-198668070-00012","article-title":"Chronic arthritis of the knee in Lyme disease. Review of the literature and report of two cases treated by synovectomy","volume":"68","author":"McLaughlin","year":"1986","journal-title":"J. Bone Joint Surg. Am."},{"issue":"5","key":"10.1016\/j.medmal.2006.01.030_bib56","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2165\/00003495-199243050-00005","article-title":"Current recommendations for the treatment of Lyme disease","volume":"43","author":"Sigal","year":"1992","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.medmal.2006.01.030_bib57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/003655401300077225","article-title":"Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis","volume":"33","author":"Karkkonen","year":"2001","journal-title":"Scand. J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.medmal.2006.01.030_bib58","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1212\/WNL.51.5.1489","article-title":"Clinical and serologic follow-up in patients with neuroborreliosis","volume":"51","author":"Treib","year":"1998","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.medmal.2006.01.030_bib59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1034\/j.1600-0404.2002.01358.x","article-title":"Chronic symptoms are common in patients with neuroborreliosis- a questionnaire follow-up study","volume":"106","author":"Vrethem","year":"2002","journal-title":"Acta Neurol. Scand."},{"issue":"22\u201323","key":"10.1016\/j.medmal.2006.01.030_bib60","first-page":"961","article-title":"Lyme meningitis: a one-year follow up controlled study","volume":"111","author":"Cimperman","year":"1999","journal-title":"Wien Klin Wochenschr"},{"issue":"6","key":"10.1016\/j.medmal.2006.01.030_bib61","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/00365540110080421","article-title":"5-y Follow-up study of patients with neuroborreliosis","volume":"34","author":"Berglund","year":"2002","journal-title":"Scand. J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.medmal.2006.01.030_bib62","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF00838171","article-title":"Prognosis of facial palsy in Borrelia\u00a0burgdorferi meningopolyradiculoneuritis","volume":"240","author":"Angerer","year":"1993","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.medmal.2006.01.030_bib63","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1542\/peds.112.2.e93","article-title":"Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease","volume":"112","author":"Vazquez","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.medmal.2006.01.030_bib64","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/318082","article-title":"Evaluation of Study Patients with Lyme Disease, 10-20-Year follow-up","volume":"183","author":"Kalish Robert","year":"2001","journal-title":"JID"},{"issue":"1","key":"10.1016\/j.medmal.2006.01.030_bib65","first-page":"98","article-title":"Long-term results in patients with Lyme arthritis following treatment with ceftriaxone","volume":"24","author":"Valesova","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2006.01.030_bib66","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1542\/peds.102.4.905","article-title":"Lyme arthritis in children: clinical epidemiology and long-term outcomes","volume":"102","author":"Gerber","year":"1998","journal-title":"Pediatrics"},{"issue":"22\u201323","key":"10.1016\/j.medmal.2006.01.030_bib67","first-page":"978","article-title":"The course of Lyme disease in different age groups","volume":"111","author":"Barskova","year":"1999","journal-title":"Wien Klin Wochenschr"},{"issue":"6","key":"10.1016\/j.medmal.2006.01.030_bib68","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/jcm.32.6.1519-1525.1994","article-title":"Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis","volume":"32","author":"Hammers-Berggren","year":"1994","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"10.1016\/j.medmal.2006.01.030_bib69","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/322669","article-title":"Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia\u00a0burgdorferi 10-20 years after active Lyme disease","volume":"33","author":"Kalish","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.01.030_bib70","first-page":"161","article-title":"Disappearance of specific immune response after successful therapy of chronic Lyme borreliosis","volume":"293","author":"Hassler","year":"2004","journal-title":"Int. J. Med. Microbiol."},{"issue":"12","key":"10.1016\/j.medmal.2006.01.030_bib71","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-131-12-199912210-00003","article-title":"Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease","volume":"131","author":"Shadick","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.medmal.2006.01.030_bib72","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF00920571","article-title":"Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients","volume":"242","author":"Kaiser","year":"1994","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.medmal.2006.01.030_bib73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.43.1_Part_1.169","article-title":"Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study","volume":"43","author":"Hammers-Berggren","year":"1993","journal-title":"Neurology"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X07000728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X07000728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:03:37Z","timestamp":1759971817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X07000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":73,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0399077X07000728"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2006.01.030","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitement et\u00a0suivi des\u00a0phases secondaire et\u00a0tertiaire de\u00a0la\u00a0borr\u00e9liose de\u00a0Lyme","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2006.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}